vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459K

vTv Therapeutics reports 2018 executive compensation

By ExecPay News

Published: March 15, 2019

vTv Therapeutics reported fiscal year 2018 executive compensation information on March 15, 2019.
In 2018, four executives at vTv Therapeutics received on average a compensation package of $370K, a 58% decrease compared to previous year.
Average pay of disclosed executives at vTv Therapeutics
Stephen L. Holcombe, Chief Executive Officer, received $459K in total, which decreased by 63% compared to 2017. 98% of Holcombe's compensation, or $450K, was in salary. Holcombe also received $9.4K in other compensation.
Larry D. Altstiel, Chief Medical Officer, received a compensation package of $413K, which decreased by 58% compared to previous year. 97% of the compensation package, or $400K, was in salary.
Rudy C. Howard, Chief Financial Officer, earned $357K in 2018, a 58% decrease compared to previous year.
Jeffrey B. Kindler, Chairman, received $250K in 2018, which decreases by 45% compared to 2017.

Related executives

Stephen Holcombe

vTv Therapeutics

Chief Executive Officer

Rudy Howard

vTv Therapeutics

Chief Financial Officer

Jeffrey Kindler

vTv Therapeutics

Chairman

Larry Altstiel

vTv Therapeutics

Chief Medical Officer

You may also like

Source: SEC filing on March 15, 2019.